Targeting the Oxysterol Receptor GPR183 to Mitigate Fibrogenesis in Idiopathic Pulmonary Fibrosis
Minh Dao Ngo, Cheng Xiang Foo, Ziying Hong, Hoang P.L. Uong, Yuanhao Yang, Helle Bielefeldt‐Ohmann, Sarah Reed, Edita Ritmejerytė, Lucy D. Burr, Viviana P. Lutzky, Simon Hall Apte, Daniel Charles Chambers, Mette M. Rosenkilde, Katharina Ronacher
Targeting GPR183 reduced lung fibrosis and inflammation in a preclinical model, supporting GPR183 as a promising new therapy.
bioRxiv · Aug 18, 2026 · PreprintImmunology